Nuvo Research and Apotex reach PENNSAID patent settlement


Canadian pharmaceutical firms Nuvo Research and Apotex have agreed a patent settlement allowing Apotex to launch a generic version of Nuvo’s arthritis treatment PENNSAID in the US in April 2014 or earlier under certain circumstances.

Nuvo Research, Apotex, PENNSAID, generics, patent settlement